The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).
 
Heather L. McArthur
Consulting or Advisory Role - Amgen; Calithera Biosciences; Lilly; Merck; OBI Pharma; Peregrine Pharmaceuticals; Roche; Spectrum Pharmaceuticals; Syndax; TapImmune Inc.
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Calithera Biosciences; Lilly; Merck; OBI Pharma; Roche; Spectrum Pharmaceuticals
Other Relationship - Lilly; OBI Pharma
 
Christopher Andrew Barker
Honoraria - Driver Group; Elsevier
Consulting or Advisory Role - Patient Resource; Pfizer
Speakers' Bureau - Omniprex
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Elekta (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Driver Group; Pfizer
 
Ayca Gucalp
Research Funding - Innocrin Pharma; Pfizer
 
Lizza Lebron-Zapata
No Relationships to Disclose
 
Yong Hannah Wen
No Relationships to Disclose
 
Cindy Kallman
No Relationships to Disclose
 
Alessandro D'Agnolo
No Relationships to Disclose
 
Micaela Rodine
No Relationships to Disclose
 
Brittany Arnold
No Relationships to Disclose
 
Zhigang Zhang
No Relationships to Disclose
 
Alice Y. Ho
No Relationships to Disclose